Internet Enduring Material sponsored by the Stanford University School of Medicine. Presented by the Department of Medicine at the Stanford University School of Medicine.
Learners are presented with an Occupational Health Updates, discussion of Peg-interferon lambda for treatment of outpatients with uncomplicated COVID-19: a randomized placebo-controlled trial. Presenters talk about the urgent need for outpatient therapeutics for COVID-19. Discusses the various types of therapies. Also discusses the Peg-interferon Lambda trial and the study design and outcomes, inclusion/exclusion criteria, safety outcomes, limitations and results.